| abstract |
Methods, compositions and kits are provided for the detection and treatment of bladder cancer. A method for detecting bladder cancer in a subject, wherein a body fluid sample or tissue sample is obtained from a control and expression of a panel of marker genes (LOC650517, FCRLB, IL1A, S100A2, MMP11, S100A7A, etc.) is detected. To detect. One or more active substances (active substances are nucleic acids, antibodies) are contacted with a sample obtained from the subject and non-cancerous cells, and the expression level of the marker panel is higher than that of the non-cancerous cells. Show that has bladder cancer, selection method None |